Kundl, Austria

Dominic De Souza

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Kundl, AT (2013 - 2014)
  • Holzkirchen, DE (2015)
  • Regau, AT (2013 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Dominic De Souza

Introduction

Dominic De Souza is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the purification of various compounds. With a total of nine patents to his name, De Souza's work has the potential to impact industrial applications significantly.

Latest Patents

One of his latest patents is titled "Process to convert technical ascomycin into purified pimecrolimus." This patent describes an improved method for converting crude ascomycin into purified pimecrolimus. The process involves chlorinating crude ascomycin with triphenylphosphine and N-chlorosuccinimide (NCS) to yield crude pimecrolimus, which is then purified using high-pressure liquid chromatography (HPLC) and subsequent crystallization. This innovation allows for the removal of close homologs of pimecrolimus without prior purification of the ascomycin starting material, making the conversion more industrially applicable and cost-effective.

Another significant patent by De Souza is focused on the "Purification of posaconazole and of posaconazole intermediates." This invention outlines a process for preparing a hydrogen chloride (HCl) salt of a specific compound. The process includes providing the compound in a suitable solvent and treating it with HCl in another solvent to obtain the desired HCl salt. These advancements showcase De Souza's expertise in pharmaceutical chemistry.

Career Highlights

Throughout his career, Dominic De Souza has worked with prominent companies in the pharmaceutical industry, including Sandoz AG and Meda AB. His experience in these organizations has contributed to his development as an inventor and has provided him with valuable insights into the industry.

Collaborations

De Souza has collaborated with notable colleagues, including Martin Albert and Hubert Sturm. These partnerships have likely facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Dominic De Souza's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to advancing chemical processes. His work not only enhances the efficiency of drug production but also has the potential to reduce costs in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…